Procedure May Relieve Agony of Spinal Cord Injuries

Published Online: Thursday, July 1, 2004

Molecular neurosurgery may someday offer pain relief to patients with spinal cord injuries. A study, reported recently in the on-line edition of Neuroscience Letters, found that a potent neurotoxin eliminated pain-transmitting rogue nerve cells that caused chronic pain in rats with paralyzing spinal cord injuries. In molecular neurosurgery, the neurotoxin acts on specific sites in the spinal cord, where the neurotoxin is incorporated into nerve cells, which then die.

The findings may help researchers better grasp the mechanisms of pain experienced by individuals after a spinal cord injury. Statistics have shown that up to 80% of individuals with spinal cord injuries develop some form of chronic pain at or below the level of paralysis.

Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues